Your browser doesn't support javascript.
loading
Incidence of tethered cord syndrome in neurofibromatosis types 1 and 2 pediatric patients: a population-level analysis.
Bhanja, Debarati; Freedman, Zachary; Sciscent, Bao Y; Moeckel, Camille; Daggubati, Lekhaj; Rizk, Elias.
Afiliación
  • Bhanja D; Department of Neurosurgery, Penn State College of Medicine, Hershey, PA, USA. dbhanja@pennstatehealth.psu.edu.
  • Freedman Z; Department of Neurosurgery, Penn State College of Medicine, Hershey, PA, USA.
  • Sciscent BY; Department of Neurosurgery, Penn State College of Medicine, Hershey, PA, USA.
  • Moeckel C; Department of Neurosurgery, Penn State College of Medicine, Hershey, PA, USA.
  • Daggubati L; Department of Neurosurgery, Penn State College of Medicine, Hershey, PA, USA.
  • Rizk E; Department of Neurosurgery, George Washington School of Medicine & Health Sciences, Washington, D.C., USA.
Childs Nerv Syst ; 40(6): 1821-1825, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38451296
ABSTRACT

PURPOSE:

Tethered spinal cord syndrome (TCS) is characterized by cutaneous attachments on the filum terminale that stretch the spinal cord, leading to musculoskeletal and urogenital sequelae. While the neurocutaneous associations with TCS remain undefined, a recent study reports a high incidence of TCS among a pediatric neurofibromatosis (NF) cohort. This present study utilizes a population-level database to estimate TCS incidence among pediatric patients with neurofibromatosis types 1 and 2 (NF1, NF2).

METHODS:

The TriNetX Research Network was queried to identify patients diagnosed with NF and/or TCS before the age of 21. Symptomatic TCS requiring surgical intervention was identified using corresponding procedural codes within 12 months following TCS diagnosis. Odds ratios (OR) were calculated to measure the associations of NF1/NF2 with TCS.

RESULTS:

19,426 pediatric NF patients were evaluated (NF1 18,383, NF2 1042). The average ages of TCS diagnosis among NF1, NF2, and non-NF patients were 12, 16, and 9 years, respectively. The incidence of TCS was 1.2% in NF1 patients and 7.3% in NF2 patients, compared to 0.074% in the general population. The associations of NF incidence with TCS were significantly increased in both NF1 (OR 16.42; 14.38-18.76) and NF2 (OR 105.58; 83.56-133.40) patients compared to the general population. Symptomatic TCS requiring surgical intervention was not significantly associated with NF1/NF2 patients compared to the general TCS population.

CONCLUSION:

This analysis demonstrates a high incidence of TCS but delayed intervention in pediatric NF patients. Considering TCS counseling, spinal MRI, and earlier intervention may be warranted for NF patients experiencing musculoskeletal symptomatology.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neurofibromatosis 2 / Neurofibromatosis 1 / Defectos del Tubo Neural Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Childs Nerv Syst Asunto de la revista: NEUROLOGIA / PEDIATRIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neurofibromatosis 2 / Neurofibromatosis 1 / Defectos del Tubo Neural Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Childs Nerv Syst Asunto de la revista: NEUROLOGIA / PEDIATRIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos